Search Results - "Sacher, M D"

Refine Results
  1. 1

    Anthranilic diamides: A new class of insecticides with a novel mode of action, ryanodine receptor activation by Cordova, D., Benner, E.A., Sacher, M.D., Rauh, J.J., Sopa, J.S., Lahm, G.P., Selby, T.P., Stevenson, T.M., Flexner, L., Gutteridge, S., Rhoades, D.F., Wu, L., Smith, R.M., Tao, Y.

    Published in Pesticide biochemistry and physiology (01-03-2006)
    “…Development of insecticides with unique modes of action is necessary to combat widespread insecticide resistance. A new class of insecticides has been…”
    Get full text
    Journal Article
  2. 2

    Fundamentals for magnetic patterning by ion bombardment of exchange bias layer systems by Ehresmann, A., Engel, D., Weis, T., Schindler, A., Junk, D., Schmalhorst, J., Höink, V., Sacher, M. D., Reiss, G.

    Published in Physica Status Solidi (b) (01-01-2006)
    “…In the present paper we investigate whether the ion bombardment induced magnetic modifications in exchange biased bilayers are stable in time, whether the…”
    Get full text
    Journal Article Conference Proceeding
  3. 3

    Reflection of femtosecond pulses from soft X-ray free-electron laser by periodical multilayers by Ksenzov, D., Grigorian, S., Hendel, S., Bienert, F., Sacher, M. D., Heinzmann, U., Pietsch, U.

    “…Recent experiments on a soft X‐ray free‐electron laser (FEL) source (FLASH in Hamburg) have shown that multilayers (MLs) can be used as optical elements for…”
    Get full text
    Journal Article Conference Proceeding
  4. 4

    Postannealing of magnetic tunnel junctions with ion-bombardment-modified exchange bias by Höink, V., Sacher, M. D., Schmalhorst, J., Reiss, G., Engel, D., Junk, D., Ehresmann, A.

    Published in Applied physics letters (11-04-2005)
    “…The influence of a postannealing procedure on the transport properties of magnetic tunnel junctions with ion-bombardment-manipulated exchange bias is…”
    Get full text
    Journal Article
  5. 5

    Thermal stability of magnetic nanostructures in ion-bombardment-modified exchange-bias systems by Höink, V., Sacher, M. D., Schmalhorst, J., Reiss, G., Engel, D., Weis, T., Ehresmann, A.

    “…In magnetic bilayer systems consisting of a ferromagnet and an antiferromagnet the strength and direction of the exchange bias coupling can be set by ion…”
    Get full text
    Journal Article
  6. 6
  7. 7
  8. 8
  9. 9

    Chemical and Magnetic Interface Properties of Tunnel Junctions With Co(2) MnSi/Co(2)FeSi Multilayer Electrode Showing Large Tunneling Magnetoresistance by Schmalhorst, J, Ebke, D, Sacher, M D, Liu, Ning-Ning, Thomas, A, Reiss, G, Hutten, A, Arenholz, E

    Published in IEEE transactions on magnetics (01-06-2007)
    “…Transport, as well as chemical and magnetic interface properties of two kinds of magnetic tunnel junctions (MTJs) with Co(2)FeSi electrode, Al-O barrier, and…”
    Get full text
    Journal Article
  10. 10
  11. 11
  12. 12
  13. 13

    Automating Access to Real-World Evidence by Gauthier, Marie-Pier, Law, Jennifer H., Le, Lisa W., Li, Janice J.N., Zahir, Sajda, Nirmalakumar, Sharon, Sung, Mike, Pettengell, Christopher, Aviv, Steven, Chu, Ryan, Sacher, Adrian, Liu, Geoffrey, Bradbury, Penelope, Shepherd, Frances A., Leighl, Natasha B.

    Published in JTO clinical and research reports (01-06-2022)
    “…Real-world evidence is important in regulatory and funding decisions. Manual data extraction from electronic health records (EHRs) is time-consuming and…”
    Get full text
    Journal Article
  14. 14

    Aluminum oxidation by a remote electron cyclotron resonance plasma in magnetic tunnel junctions by Thomas, A., Brückl, H., Sacher, M. D., Schmalhorst, J., Reiss, G.

    “…The aluminum barrier in exchange biased ( Mn–Ir/Co–Fe/AlO x / Py ) magnetic tunnel junctions was formed by oxidation with an electron cyclotron resonance…”
    Get full text
    Journal Article
  15. 15
  16. 16

    Talimogene laherparepvec (T-Vec) for the treatment of melanoma and other cancers by Grigg, Claud, MD, Blake, Zoë, BA, Gartrell, Robyn, MD, Sacher, Adrian, MD, Taback, Bret, MD, Saenger, Yvonne, MD

    Published in Seminars in oncology (01-12-2016)
    “…Talimogene laherparepvec (T-Vec) is the first live virus to be approved by the FDA for the treatment of cancer. This engineered version of herpes simplex virus…”
    Get full text
    Journal Article
  17. 17
  18. 18
  19. 19
  20. 20